{"transactions":[{"id":675155,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-08-26T10:50:10.000Z","date":"2026-08-24","kind":"sale","planned":false,"acquired":false,"shares":9370,"price":48.89,"value":458099.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $48.88 to $48.89 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":87319,"source":{"system":"sec-edgar","filing":"0001861996-26-000006","document":"wk-form4_1787741408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000186199626000006/wk-form4_1787741408.xml","form_type":"4"}},{"id":718304,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-02T13:03:38.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":636,"price":23.78,"value":15124.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98."}],"balance_after":96689,"source":{"system":"sec-edgar","filing":"0001861996-26-000004","document":"wk-form4_1782997415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000186199626000004/wk-form4_1782997415.xml","form_type":"4"}},{"id":868146,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:52:26.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":15687,"price":31.26,"value":490375.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award."}],"balance_after":96053,"source":{"system":"sec-edgar","filing":"0001861996-26-000002","document":"wk-form4_1772574742.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000186199626000002/wk-form4_1772574742.xml","form_type":"4"}},{"id":868145,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:52:26.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":15198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met."}],"balance_after":111740,"source":{"system":"sec-edgar","filing":"0001861996-26-000002","document":"wk-form4_1772574742.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000186199626000002/wk-form4_1772574742.xml","form_type":"4"}},{"id":868144,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:52:26.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":27991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant."}],"balance_after":96542,"source":{"system":"sec-edgar","filing":"0001861996-26-000002","document":"wk-form4_1772574742.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000186199626000002/wk-form4_1772574742.xml","form_type":"4"}},{"id":1095490,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-02T12:48:39.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":822,"price":25.84,"value":21240.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2025, which is the first trading day of the applicable offering period. The closing price on January 2, 2025 was $30.40."}],"balance_after":68551,"source":{"system":"sec-edgar","filing":"0001323885-25-000077","document":"wk-form4_1751460512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388525000077/wk-form4_1751460512.xml","form_type":"4"}},{"id":1229383,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:59:58.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":9870,"price":38.74,"value":382363.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award."}],"balance_after":67729,"source":{"system":"sec-edgar","filing":"0001323885-25-000019","document":"wk-form4_1741125591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388525000019/wk-form4_1741125591.xml","form_type":"4"}},{"id":1229382,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:59:58.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":6579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met."}],"balance_after":77599,"source":{"system":"sec-edgar","filing":"0001323885-25-000019","document":"wk-form4_1741125591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388525000019/wk-form4_1741125591.xml","form_type":"4"}},{"id":1229381,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:59:58.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":19359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant."}],"balance_after":71020,"source":{"system":"sec-edgar","filing":"0001323885-25-000019","document":"wk-form4_1741125591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388525000019/wk-form4_1741125591.xml","form_type":"4"}},{"id":1463339,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-07-02T20:26:02.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":707,"price":19.35,"value":13680.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77."}],"balance_after":51661,"source":{"system":"sec-edgar","filing":"0001323885-24-000100","document":"wk-form4_1719951952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388524000100/wk-form4_1719951952.xml","form_type":"4"}},{"id":1566151,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-20T12:41:34.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":1885,"price":32.16,"value":60621.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023."}],"balance_after":50954,"source":{"system":"sec-edgar","filing":"0001323885-24-000046","document":"wk-form4_1710938484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388524000046/wk-form4_1710938484.xml","form_type":"4"}},{"id":1589355,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-07T12:28:10.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":8231,"price":37.36,"value":307510.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $36.57 to $37.74 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":52839,"source":{"system":"sec-edgar","filing":"0001323885-24-000040","document":"wk-form4_1709814482.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388524000040/wk-form4_1709814482.xml","form_type":"4"}},{"id":1597345,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:45:48.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":8231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met."}],"balance_after":61070,"source":{"system":"sec-edgar","filing":"0001323885-24-000035","document":"wk-form4_1709675103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388524000035/wk-form4_1709675103.xml","form_type":"4"}},{"id":1597344,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:45:48.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":22050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant."}],"balance_after":52839,"source":{"system":"sec-edgar","filing":"0001323885-24-000035","document":"wk-form4_1709675103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388524000035/wk-form4_1709675103.xml","form_type":"4"}},{"id":1749968,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-11-03T12:40:02.000Z","date":"2023-11-01","kind":"sale","planned":true,"acquired":false,"shares":1248,"price":34.43,"value":42968.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023."}],"balance_after":30789,"source":{"system":"sec-edgar","filing":"0001323885-23-000112","document":"wk-form4_1699015194.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388523000112/wk-form4_1699015194.xml","form_type":"4"}},{"id":1821560,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-07-28T12:39:38.000Z","date":"2023-07-26","kind":"sale","planned":true,"acquired":false,"shares":3417,"price":57.09,"value":195076.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $56.75 to $57.50 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":32037,"source":{"system":"sec-edgar","filing":"0001323885-23-000099","document":"wk-form4_1690547968.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388523000099/wk-form4_1690547968.xml","form_type":"4"}},{"id":1839835,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-07-03T12:14:28.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":557,"price":38.11,"value":21227.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2023, which is the first trading day of the applicable offering period.  The closing price on January 3, 2023 was $44.84."}],"balance_after":35454,"source":{"system":"sec-edgar","filing":"0001323885-23-000079","document":"wk-form4_1688386461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388523000079/wk-form4_1688386461.xml","form_type":"4"}},{"id":1864100,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-06-07T12:43:42.000Z","date":"2023-06-06","kind":"sale","planned":true,"acquired":false,"shares":1422,"price":47.03,"value":66876.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023."}],"balance_after":34897,"source":{"system":"sec-edgar","filing":"0001323885-23-000073","document":"wk-form4_1686141814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388523000073/wk-form4_1686141814.xml","form_type":"4"}},{"id":1906344,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-05-03T20:03:00.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":4417,"price":44.83,"value":198014.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $44.31 to $45.45 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":36319,"source":{"system":"sec-edgar","filing":"0001323885-23-000049","document":"wf-form4_168314416777718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388523000049/wf-form4_168314416777718.xml","form_type":"4"}},{"id":1974606,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-03T22:16:29.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":6894,"price":38.81,"value":267556.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award."}],"balance_after":40736,"source":{"system":"sec-edgar","filing":"0001323885-23-000031","document":"wf-form4_167788176034477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388523000031/wf-form4_167788176034477.xml","form_type":"4"}},{"id":1974605,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-03T22:16:29.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":16104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant."}],"balance_after":47630,"source":{"system":"sec-edgar","filing":"0001323885-23-000031","document":"wf-form4_167788176034477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388523000031/wf-form4_167788176034477.xml","form_type":"4"}},{"id":1974604,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-03T22:16:29.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":8036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met."}],"balance_after":31526,"source":{"system":"sec-edgar","filing":"0001323885-23-000031","document":"wf-form4_167788176034477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388523000031/wf-form4_167788176034477.xml","form_type":"4"}},{"id":2214997,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-07-05T20:24:29.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":350,"price":34.73,"value":12155.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022, which is the last trading day of the applicable offering period. The closing price on June 30, 2022 was $40.86."}],"balance_after":23490,"source":{"system":"sec-edgar","filing":"0001323885-22-000093","document":"wf-form4_165705262736127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388522000093/wf-form4_165705262736127.xml","form_type":"4"}},{"id":2355315,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:30:27.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":7299,"price":69.59,"value":507937.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award."}],"balance_after":23140,"source":{"system":"sec-edgar","filing":"0001323885-22-000023","document":"wf-form4_164634299735384.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388522000023/wf-form4_164634299735384.xml","form_type":"4"}},{"id":2355314,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:30:27.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":6825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant."}],"balance_after":30439,"source":{"system":"sec-edgar","filing":"0001323885-22-000023","document":"wf-form4_164634299735384.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388522000023/wf-form4_164634299735384.xml","form_type":"4"}},{"id":2355313,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:30:27.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":7789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met."}],"balance_after":23614,"source":{"system":"sec-edgar","filing":"0001323885-22-000023","document":"wf-form4_164634299735384.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000132388522000023/wf-form4_164634299735384.xml","form_type":"4"}},{"id":2449990,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-01-04T13:35:19.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":24,"price":59.1,"value":1418.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53."}],"balance_after":15825,"source":{"system":"sec-edgar","filing":"0001209191-22-000384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000120919122000384/doc4.xml","form_type":"4"}},{"id":2645315,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2021-07-02T20:03:40.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":336,"price":79.53,"value":26722.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were sold pursuant to a 10b5-1 trading plan."}],"balance_after":15801,"source":{"system":"sec-edgar","filing":"0001209191-21-044872","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000120919121044872/doc4.xml","form_type":"4"}},{"id":2645314,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":19537,"kind":"person","name":"Dahlquist Karl S.","position":1,"cik":"0001861996","reported_name":"Dahlquist Karl S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2021-07-02T20:03:40.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":428,"price":45.72,"value":19568.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 4, 2021, which was the first trading day of the applicable offering period. The closing price on January 4, 2021 was $53.79."}],"balance_after":16137,"source":{"system":"sec-edgar","filing":"0001209191-21-044872","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861996/000120919121044872/doc4.xml","form_type":"4"}}]}